Philips NV

Equities

PHIA

NL0000009538

Advanced Medical Equipment & Technology

Real-time Euronext Amsterdam Other stock markets 09:52:14 2024-09-10 EDT			5-day change	1st Jan Change
26.82 ^EUR	-1.54%		-0.89%	+31.55%

09-06	European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading; Index Set to End Week 3.7% Lower	MT
09-03	Philips Announces Managing Director Changes for the Philips Indian Subcontinent	CI

PHILIPS NV : Barclays maintains a Buy rating

July 30, 2024 at 02:02 am

In a research note, Barclays analyst Hassan Al-Wakeel has maintained his recommendation on the stock with a Buy rating. The target price has been modified and is now set at EUR 32.50 compared to EUR 32.

Latest news about Philips NV

European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading; Index Set to End Week 3.7% Lower	09-06	MT
Philips Announces Managing Director Changes for the Philips Indian Subcontinent	09-03	CI
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading	08-29	MT
Morningstar Upgrades Philips to Buy, Boosts PT	08-28	MT
Royal Philips to Deploy Cardiovascular Care Suite for Carilion Clinic	08-20	MT
Philips: chosen by Carilion Clinic in Virginia	08-20	CF
Royal Philips' Cardiovascular Care Ecosystem Adopted by Carilion Clinic	08-20	MT
Carilion Clinic Further Expands Quality Cardiac Care Access with Latest Philips Innovations at Region's Premier Cardiovascular Institute at Crystal Spring Tower in Virginia	08-20	CI
Royal Philips, Isala Hospital Renew Partnership for Healthcare Services	08-13	MT
Philips renews partnership with Dutch hospital	08-13	CF
Philips and Dutch Isala Hospital Renews Long-Term Partnership Focused on Innovation and Affordable, Sustainable Healthcare	08-13	CI
European Equities Traded in the US as American Depositary Receipts Rise Friday	08-09	MT
Koninklijke Philips N.V. announces an Equity Buyback for ?125 million worth of its shares.	08-05	CI
Philips: share buyback plan	08-05	CF
Royal Philips Plans to Repurchase Up to $136.8 Million in Shares	08-05	MT
Koninklijke Philips N.V. authorizes a Buyback Plan.	08-04	CI
European Equities Traded in the US as American Depositary Receipts Sharply Down in Friday Trading	08-02	MT
From Mammograms to Molecules: Hologic's Quest in Women's Health Tech	07-31
PHILIPS NV : Deutsche Bank remains Neutral	07-31	ZD
PHILIPS NV : JP Morgan reiterates its Neutral rating	07-31	ZD
PHILIPS NV : Gets a Neutral rating from DZ Bank	07-30	ZD
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading	07-30	MT
PHILIPS NV : Deutsche Bank reaffirms its Neutral rating	07-30	ZD
PHILIPS NV : UBS reiterates its Neutral rating	07-30	ZD
PHILIPS NV : Goldman Sachs reaffirms its Buy rating	07-30	ZD

Chart Philips NV

Duration

Period

More charts

Company Profile

Koninklijke Philips N.V. is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The group leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Koninklijke Philips N.V. is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.

Employees

68,701

Sector

Advanced Medical Equipment & Technology

Calendar

2024-09-10 - Kepler Cheuvreux Autumn Conference

Related indices

STOXX Europe 600 Index (EUR) , AEX

More about the company